Low-dose spironolactone and cardiovascular outcomes in moderate stage Chronic Kidney Disease: a randomised controlled trial

HOBBS R., McManus R., TAYLOR C., JONES N., Rahman J., WOLSTENHOLME J., Kim S., Kwon J., JONES L., HIRST J., YU L-M., MORT S.

Type

Journal article

Publisher

Nature Research

Publication Date

2024-09-24T00:00:00+00:00

Permalink Close